Press release -
Probiotic feed additive awarded for quality and excellence
The global supplier of ingredients, Chr. Hansen, has been awarded the Grand Prix at International Veterinary Exhibition.
The product awarded is the probiotic feed additive Rumenal. Rumenal is developed by the company Medipharm, which Chr. Hansen acquired in January 2008. Rumenal is a dietary supplement used to prevent unbalance of the mineral and energy metabolisms and to support the general state of health of dairy cows.
Medipharm/Chr. Hansen, represented by Petr Mican, Managing Director, Czech Republic and one of the drivers in developing Rumenal, was congratulated on their pioneering work within probiotics for improving animal production by the Czech Minister of Agriculture, Mr. Petr Gandalovic during the Animal Vetex in Brno, Czech Republic.
“Rumenal provides several advantages to professional farming. It represents a unique composition of biological components for fast recovery of the rumenal microflora. It enhances the general well-being of the dairy cows and helps prevent eliminate problems after calving like e.g. dehydration. Furthermore it increases milk production and the general energy metabolism in dairy cows, “explains Lenka Stankova, Product Manager, Animal Health & Nutrition, Chr. Hansen.
The product has first been launched in the Czech Republic, where results are good. On farms where Rumenal is used after-calving complications have dropped from 2% in average to 0,1-0,5%.
The first of many
Rumenal is part of a strong existing and fast developing product portfolio of natural animal health and nutrition products from Chr. Hansen and Medipharm. And more will follow.
“We have identified clear synergies and set our aim high. Together Chr. Hansen and Medipharm will provide the market with the world’s best natural silage additives and further develop and grow the already unique combination of expertise within feed probiotics”, explains Jan Kuhlmann, Vice President, Animal Health & Nutrition Division, Chr. Hansen.
Topics
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.
